BRIEF published on 02/20/2026 at 21:42, 1 month 7 days ago La suspension injectable d'olanzapine de Teva obtient l'approbation de la FDA Schizophrénie Olanzapine Teva Pharmaceuticals Acceptation Par La FDA Injectable À Action Prolongée
BRIEF published on 02/20/2026 at 21:42, 1 month 7 days ago Teva's Olanzapine Injectable Suspension Gains FDA Nod Schizophrenia Olanzapine Teva Pharmaceuticals FDA Acceptance Long-acting Injectable
PRESS RELEASE published on 02/20/2026 at 21:37, 1 month 7 days ago Informations privilégiées / Autres communiqués La FDA américaine accepte le dossier de demande de mise sur le marché de l'Olanzapine LAI par Teva pour le traitement de la schizophrénie chez l'adulte. Une nouvelle option thérapeutique innovante pourrait bientôt être disponible FDA Schizophrénie Traitement Teva Olanzapine LAI
PRESS RELEASE published on 02/20/2026 at 21:37, 1 month 7 days ago Inside Information / Other news releases FDA accepts Teva's NDA for once-monthly olanzapine for schizophrenia treatment, addressing treatment gap. Teva and Medincell collaborate for innovative solution FDA Schizophrenia Medincell Olanzapine Teva
BRIEF published on 02/19/2026 at 10:33, 1 month 8 days ago Franchissement de seuil par Mirova chez MEDINCELL Euronext Paris Droits De Vote Cession D'actions Medincell Mirova
BRIEF published on 02/19/2026 at 10:33, 1 month 8 days ago Mirova crosses a threshold at MEDINCELL Euronext Paris Voting Rights Transfer Of Shares Mirova MEDICELL
PRESS RELEASE published on 02/19/2026 at 10:28, 1 month 8 days ago Franchissement de seuil Déclaration de franchissement de seuil de la société MedinCell par Mirova. Baisse à 6,44% du capital et 4,89% des droits de vote Franchissement De Seuil AMF Baisse Medincell Mirova
BRIEF published on 12/09/2025 at 14:55, 3 months 18 days ago Teva Pharmaceuticals soumet une demande d'autorisation pour Olanzapine LAI FDA Schizophrénie Medincell Teva Pharmaceuticals Olanzapine LAI
BRIEF published on 12/09/2025 at 14:55, 3 months 18 days ago Medincell and Teva Submit FDA Application for New Injectable Treatment Schizophrenia Treatment Medincell FDA Submission Teva Pharmaceuticals Olanzapine LAI
BRIEF published on 12/09/2025 at 14:55, 3 months 18 days ago Medincell et Teva soumettent une demande d'autorisation de mise sur le marché auprès de la FDA pour un nouveau traitement injectable. Traitement De La Schizophrénie Medincell Soumission À La FDA Teva Pharmaceuticals Olanzapine LAI
Published on 03/28/2026 at 01:00, 1 hour 11 minutes ago Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 1 hour 16 minutes ago Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 1 hour 21 minutes ago "Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 3 hours 26 minutes ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 3 hours 41 minutes ago Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property
Published on 03/28/2026 at 01:42, 28 minutes ago EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 4 hours 12 minutes ago Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 21:58, 4 hours 12 minutes ago Kaufman & Broad SA: Mise à disposition du Document d'Enregistrement Universel 2025
Published on 03/27/2026 at 20:08, 6 hours 2 minutes ago EQS-Adhoc: CECONOMY AG: Information on the ongoing public takeover process – uncertainty regarding FDI clearance in Austria
Published on 03/27/2026 at 19:30, 6 hours 40 minutes ago Turning Potential into Reality: Future 500 Ignites Scale-Up Momentum in Europe
Published on 03/27/2026 at 19:06, 7 hours 4 minutes ago Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 18:52, 7 hours 18 minutes ago Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 7 hours 18 minutes ago Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025
Published on 03/27/2026 at 18:40, 7 hours 30 minutes ago 2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
